1,422
Views
32
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia

, , , , , , , , & show all
Pages 2281-2288 | Received 17 Jun 2015, Accepted 08 Jan 2016, Published online: 05 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Xiang Zhang, Yuqing Tu, Juan Shen, Yufeng Feng, Houshi Ma, Lian Bai, Xiaoli Li, Zhihong Lin, Lijun Dai, Feiran Gong, Tianyu Lu, Jiazi Zhou, Hanqing Chen, Quansheng Lv, Ziling Zhu & Changgeng Ruan. (2022) Effectiveness and safety of leukapheresis in hyperleukocytic leukemias: a retrospective multicenter study. Leukemia & Lymphoma 63:11, pages 2636-2644.
Read now
Jennifer Zhao, Jan Philipp Bewersdorf, Sara Jaszczur, Andrew Kowalski, Sarah Perreault, Molly Schiffer, Steven Gore, Nikolai Podoltsev, Thomas Prebet, Rory Shallis & Amer M. Zeidan. (2021) High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis. Leukemia & Lymphoma 62:5, pages 1195-1202.
Read now
Rory M. Shallis, Maximilian Stahl, Jan Philipp Bewersdorf, Jeanne E. Hendrickson & Amer M. Zeidan. (2020) Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits. Expert Review of Hematology 13:5, pages 489-499.
Read now
Marco Cerrano, Valérie Seegers, Emmanuel Raffoux, Florence Rabian, Marie Sébert, Raphael Itzykson, Virginie Lemiale, Lionel Adès, Nicolas Boissel, Hervé Dombret, Elie Azoulay & Etienne Lengliné. (2020) Predictors and outcomes associated with hydroxyurea sensitivity in acute myeloid leukemia patients with high hyperleukocytosis. Leukemia & Lymphoma 61:3, pages 737-740.
Read now

Articles from other publishers (28)

Tuğcan ALP KIRKIZLAR & Ahmet Muzaffer DEMİR. (2023) Evaluation of leukapheresis and leukapheresis with additional cytoreduction in acute leukemia with hyperleukocytosis. Turkish Journal of Internal Medicine 5:3, pages 191-198.
Crossref
Marco Cerrano, Sylvie Chevret, Emmanuel Raffoux, Florence Rabian, Marie Sébert, Sandrine Valade, Raphael Itzykson, Virginie Lemiale, Lionel Adès, Nicolas Boissel, Hervé Dombret, Elie Azoulay & Etienne Lengliné. (2023) Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis. Annals of Hematology 102:4, pages 761-768.
Crossref
Fernando De la Garza-Salazar, Andrés Gómez-De León, David Gómez-Almaguer & Perla R. Colunga-Pedraza. (2023) Vinblastine as a bridge to 7 + 3 in acute myeloid leukaemia. Annals of Hematology 102:2, pages 487-489.
Crossref
Martin Jädersten, Ingrid Lilienthal, Nikolaos Tsesmetzis, Magda Lourda, Sofia Bengtzén, Anna Bohlin, Cornelia Arnroth, Tom Erkers, Brinton Seashore‐Ludlow, Géraldine Giraud, Giti S. Barkhordar, Sijia Tao, Linda Fogelstrand, Leonie Saft, Päivi Östling, Raymond F. Schinazi, Baek Kim, Torsten Schaller, Gunnar Juliusson, Stefan Deneberg, Sören Lehmann, Georgios Z. Rassidakis, Martin Höglund, Jan‐Inge Henter & Nikolas Herold. (2022) Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial. Journal of Internal Medicine 292:6, pages 925-940.
Crossref
Huai-Yu Wang, Sha Gong, Guo-Hui Li, Ya-Zhou Yao, Yin-Suo Zheng, Xiao-Hong Lu, Su-Hua Wei, Wei-Wei Qin, Hai-Bo Liu, Meng-Chang Wang, Jie-Ying Xi, Li-Mei Chen, Mei Zhang, Xin-Xin Zhang, Hui-Yun Zhang, Cheng-Sheng Zhang, David N. Wald, Hong-Hu Zhu, Li Liu & Peng-Cheng He. (2022) An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial). Blood Cancer Journal 12:11.
Crossref
Mihail Cotorogea-Simion, Bogdan Pavel, Sebastian Isac, Teodora Telecan, Irina-Mihaela Matache, Anca Bobirca, Florin-Teodor Bobirca, Razvan Rababoc & Gabriela Droc. (2022) What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature. Medicina 58:9, pages 1215.
Crossref
Sofiane Fodil, Sylvie Chevret, Camille Rouzaud, Sandrine Valade, Florence Rabian, Eric Mariotte, Emmanuel Raffoux, Raphael Itzykson, Nicolas Boissel, Marie Sébert, Lionel Adès, Lara Zafrani, Elie Azoulay & Etienne Lengliné. (2022) Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications. PLOS ONE 17:7, pages e0270744.
Crossref
Karin Palmowski, Urte Sommerwerck & Thomas Luft. 2022. Seltene Lungenerkrankungen. Seltene Lungenerkrankungen 521 536 .
Ryan T Ngo, Amanda L Webb McAdams & Anthony Furiato. (2021) Acute Myeloid Leukemia Complicated by Hyperleukocytosis and Leukostasis in the Emergency Department. Cureus.
Crossref
René López, Rodrigo Pérez-Araos, Fernanda Baus, Camila Moscoso, Álvaro Salazar, Jerónimo Graf, José Miguel Montes & Suraj Samtani. (2021) Outcomes of Sepsis and Septic Shock in Cancer Patients: Focus on Lactate. Frontiers in Medicine 8.
Crossref
Christian Récher. (2021) Clinical Implications of Inflammation in Acute Myeloid Leukemia. Frontiers in Oncology 11.
Crossref
Landis R. Walsh, Chaofan Yuan, James T. Boothe, Heather E. Conway, Andres E. Mindiola-Romero, Odeth O. Barrett-Campbell, Swaroopa Yerrabothala & Frederick Lansigan. (2021) Acute myeloid leukemia with hepatic infiltration presenting as obstructive jaundice. Leukemia Research Reports 15, pages 100251.
Crossref
Jenna Spring & Laveena Munshi. (2021) Oncologic Emergencies. Critical Care Clinics 37:1, pages 85-103.
Crossref
Petra Grami, Sorayah S. Bourenane, Danielle Milling, Karen McFarland, Robert T. Drew & Linda Koppy. 2021. Oncologic Emergency Medicine. Oncologic Emergency Medicine 83 107 .
Jan P. Bewersdorf, Smith Giri, Martin S. Tallman, Amer M. Zeidan & Maximilian Stahl. (2020) Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia—A systematic review and meta‐analysis. Transfusion 60:10, pages 2360-2369.
Crossref
Sean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, Cynthia BJ Paulin, Lakshmi Sandhow, Juliane Kutzner, Ida Hed Myrberg, Sarah S Bunten, Hanna Axelsson, Si Min Zhang, Azita Rasti, Petri Mäkelä, Si'Ana A Coggins, Sijia Tao, Sharda Suman, Rui M Branca, Georgios Mermelekas, Elisée Wiita, Sun Lee, Julian Walfridsson, Raymond F Schinazi, Baek Kim, Janne Lehtiö, Georgios Z Rassidakis, Katja Pokrovskaja Tamm, Ulrika Warpman‐Berglund, Mats Heyman, Dan Grandér, Sören Lehmann, Thomas Lundbäck, Hong Qian, Jan‐Inge Henter, Torsten Schaller, Thomas Helleday & Nikolas Herold. (2020) Ribonucleotide reductase inhibitors suppress SAMHD 1 ara‐ CTP ase activity enhancing cytarabine efficacy . EMBO Molecular Medicine 12:3.
Crossref
Abdulkerim Yıldız, Senem Maral, Murat Albayrak, Çiğdem Pala, Pınar Cömert, Hacer Berna Afacan Öztürk & Osman Şahin. (2020) Are the conventional risk factors still valid for acute myeloid leukemia patients?. Konuralp Tıp Dergisi, pages 5-11.
Crossref
Mahesh Swaminathan & Kiran Naqvi. 2020. Oncologic Critical Care. Oncologic Critical Care 1489 1497 .
Lara Zafrani, Emmanuel Canet & Michael Darmon. (2019) Understanding tumor lysis syndrome. Intensive Care Medicine 45:11, pages 1608-1611.
Crossref
Morgan L Trepte, Jessica J Auten, Stephen M Clark & Hendrik W van Deventer. (2018) Dose-related mucositis with hydroxyurea for cytoreduction in acute myeloid leukemia. Journal of Oncology Pharmacy Practice 25:4, pages 801-805.
Crossref
Hang He, Jinjing Zhang, Yi Qu, Yue Wang, Yan Zhang, Xiaojing Yan, Yan Li & Rui Zhang. (2019) Novel tumor‑suppressor FOXN3 is downregulated in adult acute myeloid leukemia. Oncology Letters.
Crossref
Mahesh Swaminathan & Kiran Naqvi. 2019. Oncologic Critical Care. Oncologic Critical Care 1 9 .
Sarah Bertoli, Suzanne Tavitian, Muriel Picard, Françoise Huguet, François Vergez, Eric Delabesse, Audrey Sarry, Emilie Bérard & Christian Récher. (2018) Hydroxyurea prior to intensive chemotherapy in AML with moderate leukocytosis. Leukemia Research 75, pages 7-10.
Crossref
Jan Braess. (2018) Hyperleukozytose und Leukostase bei der akuten myeloischen Leukämie. Im Focus Onkologie 21:11, pages 55-63.
Crossref
Peter H. Wiernik. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 375 407 .
Andry Van de Louw. (2017) Effect of leukapheresis on blood coagulation in patients with hyperleukocytic acute myeloid leukemia. Transfusion and Apheresis Science 56:2, pages 214-219.
Crossref
Sherif M. Badawy. (2016) The Use of Hydroxyurea and Leukapheresis in Childhood Acute Leukemia With Hyperleukocytosis. Journal of Pediatric Hematology/Oncology 38:5, pages 407-407.
Crossref
É. Lengliné. (2016) Place de la biologie moléculaire des hémopathies malignes pour le réanimateurMolecular biology of the hematology neoplasms: What should know the intensivist?. Réanimation 25:S3, pages 115-118.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.